ACCREDITATION STATUS:

UKAS accredited proficiency testing provider No. 7795

CLINICAL APPLICATION:

Paraneoplastic autoantibodies are seen with a variety of neurological manifestations and can be associated with an underlying malignancy

PURPOSE OF PROGRAMME:

Autoimmunity EQA scheme

ANALYTES:

PROGRAMME OF ANALYSIS:

Data entry is via the web for the submission of results. Data analysis is commenced 21 days after sample dispatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics

DATA ANALYSIS:

Qualitative responses are assessed in relation to the designated response

PERFORMANCE SCORING:

MI scoring

PERFORMANCE MONITORING:

Laboratory performance is classified in terms of OMIS derived from the qualitative responses for all analytes for which the laboratory is registered over a running analytical window of 6 Distributions (12 months)

PERSISTENT POOR PERFORMANCE:

Defined as being in the Poor Performance category for two or more successive Distributions